These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers? Hodge RG; Schaefer A; Howard SV; Der CJ Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579 [TBL] [Abstract][Full Text] [Related]
3. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells. O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858 [TBL] [Abstract][Full Text] [Related]
4. Variegated RHOA mutations in human cancers. Kataoka K; Ogawa S Exp Hematol; 2016 Dec; 44(12):1123-1129. PubMed ID: 27693615 [TBL] [Abstract][Full Text] [Related]
5. Cell type-specific signaling function of RhoA GTPase: lessons from mouse gene targeting. Zhou X; Zheng Y J Biol Chem; 2013 Dec; 288(51):36179-88. PubMed ID: 24202176 [TBL] [Abstract][Full Text] [Related]
6. Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling. Kalpana G; Figy C; Yeung M; Yeung KC Sci Rep; 2019 Nov; 9(1):16351. PubMed ID: 31705019 [TBL] [Abstract][Full Text] [Related]
7. Novel cardiovascular protective effects of RhoA signaling and its therapeutic implications. Soh JEC; Shimizu A; Sato A; Ogita H Biochem Pharmacol; 2023 Dec; 218():115899. PubMed ID: 37907138 [TBL] [Abstract][Full Text] [Related]
8. RhoA: a dubious molecule in cardiac pathophysiology. Kilian LS; Voran J; Frank D; Rangrez AY J Biomed Sci; 2021 Apr; 28(1):33. PubMed ID: 33906663 [TBL] [Abstract][Full Text] [Related]
9. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer. Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312 [TBL] [Abstract][Full Text] [Related]
10. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells. Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196 [TBL] [Abstract][Full Text] [Related]
11. RhoA- and RhoD-dependent regulatory switch of Galpha subunit signaling by PAR-1 receptors in cellular invasion. Nguyen QD; Faivre S; Bruyneel E; Rivat C; Seto M; Endo T; Mareel M; Emami S; Gespach C FASEB J; 2002 Apr; 16(6):565-76. PubMed ID: 11919159 [TBL] [Abstract][Full Text] [Related]
12. Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine. Hu L; Zhang X; Zang S Cancer Biol Med; 2024 Aug; 21(9):754-68. PubMed ID: 39119774 [TBL] [Abstract][Full Text] [Related]
13. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells. Wang L; Yang L; Luo Y; Zheng Y J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257 [TBL] [Abstract][Full Text] [Related]
14. RhoA Signaling in Neurodegenerative Diseases. Schmidt SI; Blaabjerg M; Freude K; Meyer M Cells; 2022 May; 11(9):. PubMed ID: 35563826 [TBL] [Abstract][Full Text] [Related]
15. Gain-of-Function Zhang H; Schaefer A; Wang Y; Hodge RG; Blake DR; Diehl JN; Papageorge AG; Stachler MD; Liao J; Zhou J; Wu Z; Akarca FG; de Klerk LK; Derks S; Pierobon M; Hoadley KA; Wang TC; Church G; Wong KK; Petricoin EF; Cox AD; Lowy DR; Der CJ; Bass AJ Cancer Discov; 2020 Feb; 10(2):288-305. PubMed ID: 31771969 [TBL] [Abstract][Full Text] [Related]
16. Optogenetic control of small GTPases reveals RhoA mediates intracellular calcium signaling. Inaba H; Miao Q; Nakata T J Biol Chem; 2021; 296():100290. PubMed ID: 33453281 [TBL] [Abstract][Full Text] [Related]
17. RHOA takes the RHOad less traveled to cancer. Schaefer A; Der CJ Trends Cancer; 2022 Aug; 8(8):655-669. PubMed ID: 35568648 [TBL] [Abstract][Full Text] [Related]
18. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration. Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-345-5p suppresses cell growth of lung adenocarcinoma by regulating ras homolog family member A (RhoA) and Rho/Rho associated protein kinase (Rho/ROCK) pathway. Zhou QY; Gui SY; Zhang P; Wang M Chin Med J (Engl); 2021 Oct; 134(21):2619-2628. PubMed ID: 34748526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]